[ALNY] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 48.88%
YoY- 19.72%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 593,166 439,718 335,035 258,535 163,562 71,681 21,033 74.37%
PBT -193,958 -137,687 -207,021 -260,302 -243,599 -276,583 -211,080 -1.39%
Tax -110,195 183 472 -1,842 -59 -398 361 -
NP -83,763 -137,870 -207,493 -258,460 -243,540 -276,185 -211,441 -14.28%
Tax Rate - - - - - - - -
Total Cost 676,929 577,588 542,528 516,995 407,102 347,866 232,474 19.47%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -14.12 -31.35 -61.93 -99.97 -148.90 -385.30 -1,005.28 -50.84%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.65 -1.10 -1.68 -2.16 -2.09 -2.47 -2.09 -17.67%
EPS Diluted -0.65 -1.10 -1.68 -2.16 -2.09 -2.47 -2.09 -17.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.